BMRN vs MGNI · P/E 40, rev $1.76B vs P/E 37, rev $357.2M
Biomarin Pharmaceutical Inc (BMRN) versus Magnite Inc (MGNI) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Magnite Inc (MGNI) is a advertising agencies company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MGNI revenue for 2026-06-30 was $357.2M. Net income was $23.8M. MGNI currently screens at market cap $2.14B and trailing P/E 37.2.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MGNI currently screens at market cap $2.14B and trailing P/E 37.2.
Not investment advice. Open the BMRN and MGNI stock pages for the full models.
Not investment advice.